The first healthcare company to go full Bitcoin treasury — with a former OKEx exec on board.
Prenetics Global (NASDAQ: PRE), a health-tech firm backed by David Beckham, just became the first in its industry to bet big on Bitcoin — acquiring 187.42 BTC (worth 20M) and adding former OKEx COO Andy Cheung to its board. Healthcare is getting a crypto upgrade.
Prenetics isn’t playing it safe.
The company’s board has approved a bold plan to allocate the majority of its 117M balance sheet into Bitcoin — a move inspired by MicroStrategy and Metaplanet.
But this isn’t just “buy and hold.” Prenetics is planning:
CEO Danny Yeung said it best:
“We’re at the dawn of a new era where genomics, personalized medicine, and digital assets intersect.”
To pull this off, they’ve tapped Andy Cheung, ex-COO of OKEx, one of the largest crypto exchanges in the world. He’s managed billions in crypto trades and is bringing deep operational crypto experience to the table.
His mission? Build a dynamic crypto treasury, not just another cold wallet.
While David Beckham isn’t directly involved in the Bitcoin plan, his backing helps give the company cultural weight.
And they’re not alone:
Prenetics sits right at the center of that Venn diagram.
Prenetics isn’t stopping with treasury moves.
They’re rolling out crypto payments for consumers:
The plan? Let customers pay in crypto, while the company earns in BTC, creating a closed-loop Bitcoin economy.
Prenetics is debt-free, sitting on 66M in cash, and forecasting 80–100M revenue in 2025. Their rapid growth in consumer health gives them a strong base to take calculated risks.
Plus, crypto insiders like:
...are backing the strategy.
🏥 Prenetics bought 20M of BTC and plans to go deeper 🧠 They added OKEx’s former COO to lead the charge 💸 They’ll soon accept crypto payments for genomics and wellness products 📈 Their treasury plan includes yield, lending, and derivatives 📣 They want to lead Bitcoin adoption in healthcare
Bitcoin meets personalized medicine — and this might be the model every Web3-native company copies next.
Have questions or want to collaborate? Reach us at: info@ath.live